Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : VOLTAIRE'S PORCH-MODERATED -- Ignore unavailable to you. Want to Upgrade?

To: Dealer who wrote (40088)	8/8/2001 10:29:04 PM
From: stockman_scott	Read Replies (1) \| Respond to of 65232

Oracle VP Sees No Turnaround in N.America Wednesday August 8 4:07 PM ET BOSTON (Reuters) - Oracle Corp.'s (Nasdaq:ORCL - news) vice president of sales in North America on Wednesday said he saw no sign of a turnaround among customers, who remain bent on conserving cash rather than making investments. ``We believe we have kind of hit the bottom,'' George Roberts, an Oracle executive vice president, said at a U.S. Bancorp Piper Jaffray technology conference in Boston. ``We think we have our feet on solid ground. But the marketplace isn't turning. Customers are not freeing up their capital. They are very focused on capital preservation.'' The world's No. 2 software maker faces a tough sell as corporations only spend money on their top projects. Roberts dismissed a recent story in the Wall Street Journal that suggested Oracle's 11i software product, a suite of applications to manage corporate operations, has not gained traction among large corporations. When asked if 11i sales were on track, Roberts replied, ''We're very comfortable with the interest we are seeing from customers. It's coming along very nicely and we're very pleased with where we are at''. Roberts said 11i has 572 live customers and another 3,500 customers are implementing the do-it-all software product, which handles human resource functions, sales, supply chain management and customer relations management.

To: Dealer who wrote (40088)	8/9/2001 2:20:09 AM
From: stockman_scott	Read Replies (1) \| Respond to of 65232

Bill Gates' Eleven Rules... Message 16185881 Best Regards, Scott

To: Dealer who wrote (40088)	8/9/2001 6:20:45 PM
From: stockman_scott	Respond to of 65232

Divided Americans still ponder appropriateness of stem cell funding WASHINGTON, Aug 9 (AFP) The stem cell funding debate has divided Americans, with advocates on both sides asserting that they speak in their own way for the sanctity of human life. At recent legislative hearings and press conferences, advocates of the ground-breaking research have trotted out children suffering from diabetes and other ailments, saying that stem cell experiments could lead to medical breakthroughs for crippling or deadly infirmities. For their part, the other side counters at the same events with fetching toddlers -- children conceived from fertilized eggs rescued from fertility clinics -- the very embryos that would be destroyed by stem-cell researchers. These embryos should be made available for "adoption" by infertile couples, instead of being used for research, opponents say, insisting that every time egg and sperm unite, there is a potential for human life which must be respected and fostered. President George W. Bush, a fervent foe of abortion, has been wrestling for several weeks with the controversial issue of allowing government funding for the research, which scientists say could yield breakthrough cures for a wide array of ailments from Alzheimer's, Parkinson's disease and cancer. The president has announced that he will make his decision known late Thursday, even as many Americans struggle with their own decisions. A small majority of Americans, 55 percent, support federal funding for stem cell research using embryos already destined to be destroyed by fertility clinics, according to a poll conducted earlier this week by the Gallup organization for the daily newspaper USA Today and the CNN television network. Support for the federal funding drops to 46 percent however, when embryos are created for research purposes. And just 28 percent of those queried were in favor of funding on embryos cloned from human cells. Divorced from the issue of federal funding however, American express much stronger support for embryonic stem cell research. A survey last month by the Harris polling organization of 1,011 adults found that Americans favored such research by 61 percent to 21 percent. The intense debate has collided at the intersection of conflicting ethical, emotional, and religious values. Politically however, there are no clear dividing lines, despite the fact that debates on abortion and similar issues have riven legislators almost entirely along party lines. In the US House of Representatives for example, some 40 Republicans and at least seven Senate Republicans are supporters of funding -- including staunch conservatives like Orrin Hatch of Utah and Strom Thurmond of South Carolina. Late last month Pope John Paul II urged President Bush, who was visiting the pontiff at his summer retreate in Italy, to "show the world the path" to a "humane future" by opposing embryonic stem cell research. US Catholics however have diverged from the pope, approving of the research -- without federal funding -- by 61 to 24 percent. Meanwhile, Americans identifying themselves as "born-again Christians" favor the research by 50 to 29 percent.